EI
EAM Investors Portfolio holdings
AUM
$660M
This Quarter Return
+46.64%
1 Year Return
+271.72%
3 Year Return
+5,059.16%
5 Year Return
+72,876.1%
10 Year Return
+9,525,948.1%
AUM
$642M
AUM Growth
+$642M
(+14%)
Cap. Flow
-$12.6M
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
10.61%
Holding
350
New
118
Increased
46
Reduced
65
Closed
119
Top Buys
| 1 |
Aaon
AAON
|
$5.52M |
| 2 |
Sweetgreen
SG
|
$5.26M |
| 3 |
Dycom Industries
DY
|
$5.05M |
| 4 |
Ryman Hospitality Properties
RHP
|
$5.03M |
| 5 |
Commault Systems
CVLT
|
$4.84M |
Top Sells
| 1 |
Viking Therapeutics
VKTX
|
$7.87M |
| 2 |
MACOM Technology Solutions
MTSI
|
$4.91M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$4.89M |
| 4 |
Qualys
QLYS
|
$4.82M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$4.81M |
Sector Composition
| 1 | Industrials | 26.88% |
| 2 | Healthcare | 22.24% |
| 3 | Technology | 20.59% |
| 4 | Consumer Discretionary | 13.24% |
| 5 | Financials | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
RadNet
RDNT
$5.52B
| $3.48M | 0.54% | 71,617 -22,839 | -24% | -$1.11M |
|
102
Glaukos
GKOS
$5.5B
| $3.48M | 0.54% | 36,868 -9,460 | -20% | -$892K |
|
103
Paymentus
PAY
$4.88B
| $3.45M | 0.54% | +151,790 | New | +$3.45M |
|
104
nVent Electric
NVT
$14.5B
| $3.44M | 0.54% | 45,677 +706 | +2% | +$53.2K |
|
105
Abercrombie & Fitch
ANF
$4.46B
| $3.41M | 0.53% | 27,234 -11,037 | -29% | -$1.38M |
|
|
LBPH
106
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $3.38M | 0.53% | +156,565 | New | +$3.38M |
|
107
Medpace
MEDP
$13.4B
| $3.37M | 0.53% | 8,341 -4,087 | -33% | -$1.65M |
|
108
Liquidia Corp
LQDA
$2.38B
| $3.37M | 0.53% | +228,514 | New | +$3.37M |
|
109
Powell Industries
POWL
$3.21B
| $3.34M | 0.52% | 23,485 -14,808 | -39% | -$2.11M |
|
110
Napco Security Technologies
NSSC
$1.36B
| $3.28M | 0.51% | +81,753 | New | +$3.28M |
|
111
Griffon
GFF
$3.55B
| $3.23M | 0.5% | 44,103 -6,490 | -13% | -$476K |
|
112
Biohaven
BHVN
$1.63B
| $3.19M | 0.5% | 58,364 -33,487 | -36% | -$1.83M |
|
113
Iovance Biotherapeutics
IOVA
$807M
| $3.16M | 0.49% | +213,336 | New | +$3.16M |
|
114
Immunome
IMNM
$828M
| $3.16M | 0.49% | +127,980 | New | +$3.16M |
|
115
Modine Manufacturing
MOD
$7.15B
| $3.12M | 0.49% | 32,759 -21,193 | -39% | -$2.02M |
|
116
Collegium Pharmaceutical
COLL
$1.22B
| $3.1M | 0.48% | +79,949 | New | +$3.1M |
|
117
4D Molecular Therapeutics
FDMT
$288M
| $3.07M | 0.48% | +96,225 | New | +$3.07M |
|
118
Scorpio Tankers
STNG
$2.57B
| $3M | 0.47% | +41,868 | New | +$3M |
|
119
Vaxcyte
PCVX
$4B
| $2.99M | 0.47% | +43,732 | New | +$2.99M |
|
|
ALPN
120
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $2.97M | 0.46% | 74,899 -87,786 | -54% | -$3.48M |
|
121
CleanSpark
CLSK
$2.66B
| $2.95M | 0.46% | 139,283 -156,642 | -53% | -$3.32M |
|
122
Celldex Therapeutics
CLDX
$1.47B
| $2.94M | 0.46% | +70,115 | New | +$2.94M |
|
123
Crane Co
CR
$10.7B
| $2.93M | 0.46% | 21,698 -10,256 | -32% | -$1.39M |
|
124
Cytokinetics
CYTK
$4.23B
| $2.85M | 0.44% | 40,625 -6,580 | -14% | -$461K |
|
125
Skyward Specialty Insurance
SKWD
$1.96B
| $2.84M | 0.44% | 75,784 -18,602 | -20% | -$696K |
|